iTeos Therapeutics CEO Michel Detheux's 2022 pay jumps 88% to $11M
iTeos Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
iTeos Therapeutics reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at iTeos Therapeutics received on average a compensation package of $5.4M, a 9% increase compared to previous year.
Average pay of disclosed executives at iTeos Therapeutics
Michel Detheux, Chief Executive Officer, received $11M in total, which increased by 88% compared to 2021. 88% of Detheux's compensation, or $9.2M, was in option awards. Detheux also received $311K in non-equity incentive plan, $556K in salary, $359K in stock awards, as well as $56K in other compensation.
Joanne Jenkins Lager, Chief Medical Officer, received a compensation package of $2.9M, which decreased by 43% compared to previous year. 78% of the compensation package, or $2.2M, was in option awards.
Matthew Call, Chief Operating Officer, earned $2.9M in 2022, a 32% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2023.